Au6Cu2 集群具有高电子亲和度和氧模仿性质,用于低毒瘤放射敏感化
Xueli Zhao1, Jingpeng Han1, Junqi Liu2
1Zhengzhou University, College of chemistry, CHINA.
Angewandte Chemie (International ed. in English)
|May 19, 2025
概括
这项研究引入了新的基功能化金铜 (NO2-Au6Cu2) 集群,以克服缺氧瘤中的电阻. 这些集群通过模仿氧气和损害DNA修复来增强放射治疗,为癌症治疗提供了一种新的策略.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 辐射疗法 辐射疗法
背景情况:
- 瘤中的缺氧导致放射电阻,通过防止DNA损伤固定,阻碍放射治疗的有效性.
- 化学辐射敏感剂,如胺醇,是有前途的,但具有剂量依赖的副作用和有限的疗效.
- 开发针对缺氧瘤细胞的新策略对于改善放射治疗结果至关重要.
研究的目的:
- 合成和评估基功能化的Au6Cu2 (NO2-Au6Cu2) 集群作为低氧瘤的放射敏感剂.
- 为了研究界面连接体电子亲和力在金属集群的放射敏感性质中的作用.
- 探索低氧选择性毒性和放射敏感性增强的机制.
主要方法:
- 合成酸功能化的Au6Cu2集群.
- 通过减少酶诱导的基质生成介导的缺氧选择性毒性的评估.
- 评估谷氨 (GSH) 耗尽和反应性氧物种 (ROS) 清除.
- 在低氧条件下对敏感增强比率的量化.
主要成果:
- NO2-Au6Cu2集群通过激素生成和GSH耗尽显示出低氧选择性毒性.
- 界面连接体的电子亲和力显著影响了集群的电子亲和力和缺氧细胞毒性.
- NO2-Au6Cu2集群表现出高的敏感度增强比率,增加了放射治疗的疗效.
- 集群利用黄金集群属性和氧模仿效应来损害DNA修复.
结论:
- 基功能化的Au6Cu2集群代表了对放射性低氧瘤的新有效策略.
- 基于金属集群的放射敏感剂提供了一种有前途的方法来克服放射疗法耐药性.
- 用集成的纳米材料和化学敏感剂向缺氧可以显著改善癌症治疗结果.
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:46Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K